Genital Warts genital wart medication genital wart remover More than 30 types of HPV can infect the genital tract , genital wart remover , genital wart medicationMost HPV infections are asymptomatic, unrecognized, or subclinical , genital wart remover , genital wart medicationVisible genital warts usually are caused by HPV types 6 or 11 , genital wart remover , genital wart medication11 , genital wart remover , genital wart medicationOther HPV types in genital wart medication the anogenital region (e.g., types 16, 16, 18, 31, 33, and 35) have been strongly associated with cervical neoplasia , genital wart remover , genital wart medicationDiagnosis of genital warts can be confirmed by biopsy, although biopsy biopsy is needed only under certain circumstances (e.g., if genital wart medication genital wart remover the diagnosis is uncertain; the lesions do not respond to standard therapy; the disease worsens worsens during therapy; genital wart remover the patient is immunocompromised; or warts are pigmented, pigmented, indurated, fixed, and ulcerated) genital wart medication , genital wart remover , genital wart medicationNo data support the use of type-specific HPV nucleic acid tests in the routine diagnosis or management of visible genital warts , genital wart remover , genital wart medication In addition to the external genitalia genitalia (i.e., genital genital wart medication genital wart remover the penis, vulva, scrotum, perineum, and perianal skin) , genital warts can occur on the uterine cervix and in the vagina, urethra, anus, and mouth; these warts are sometimes symptomatic , genital wart remover , genital wart medicationIntra-anal warts warts genital wart medication are seen predominantly in patients who have had receptive anal intercourse; these these warts genital wart remover are distinct from perianal warts, which can occur in men and women who do not have a history of anal anal sex , genital wart remover , genital wart medicationIn addition to genital wart medication the genital area, HPV types 6 and 11 have been associated with conjunctival, nasal, oral, and laryngeal warts , genital wart remover , genital wart medicationHPV types 6 6 and 11 rarely genital wart remover are associated with invasive squamous squamous cell carcinoma of genital wart medication the external genitalia , genital wart remover , genital wart medicationDepending on the size and anatomic location, genital warts can be painful, friable, and pruritic, although they are commonly asymptomatic , genital wart remover , genital wart medication HPV types 16, 18, 31, 33, 33, and 35 genital wart wart medication genital wart remover are found occasionally in visible genital warts and have been associated with external genital (i.e., vulvar, penile, and anal) squamous intraepithelial neoplasia (i.e., squamous cell carcinoma in situ, bowenoid papulosis, Erythroplasia Erythroplasia of Queyrat, or Bowen's disease of genital wart medication the genitalia) , genital wart remover , genital wart medicationThese HPV types also have have been associated with vaginal, anal, and cervical intraepithelial dysplasia and squamous cell carcinoma , genital wart remover , genital wart medicationPatients who have visible genital warts warts can be infected simultaneously with multiple HPV types , genital wart remover , genital wart medicationgenital wart medication genital wart remover Treatment The primary goal of treating visible genital warts is the removal of symptomatic warts , genital wart remover , genital wart medicationIn most most patients, treatment can induce wart-free periods , genital wart remover , genital wart medicationperiods , genital wart remover , genital wart medicationIf left untreated, visible genital warts may resolve on their own, remain unchanged, or increase in size or number , genital wart remover , genital wart medicationDetermining whether treatment of genital warts will reduce transmission is difficult, because no laboratory genital wart medication laboratory marker of infectivity has been established genital wart remover established and because clinical studies evaluating genital wart medication genital wart remover the persistence of HPV DNA in genital tissue after treatment have shown variable results , genital wart remover , genital wart medicationExisting data indicate that currently available therapies for for genital warts may reduce, but probably do not eradicate, infectivity , genital wart remover , genital wart medicationWhether genital wart medication the reduction in viral DNA DNA genital wart remover that results from current treatment regimens impacts future transmission remains unclear , genital wart remover , genital wart medicationNo evidence indicates that either the genital wart medication the presence of genital warts or their treatment is associated with the development of cervical cancer , genital wart remover , genital wart medication Regimens Treatment of genital warts should be guided by the preference of of genital wart remover the patient, the available available resources, and genital wart medication the experience of the health-care provider , genital wart remover , genital wart medicationNo definitive evidence suggests that any of the available treatments is superior to the others, and no single treatment is ideal for all patients or or all warts , genital wart remover , genital wart medicationgenital wart medication The use of of locally developed and monitored treatment algorithms has been associated with improved clinical outcomes and should be encouraged , genital wart remover , genital wart medicationBecause of uncertainty regarding genital wart remover the effect of treatment on future transmission transmission and genital wart medication the possibility for spontaneous resolution, an acceptable alternative for some patients is to forego treatment and await await spontaneous resolution , genital wart remover , genital wart medicationgenital wart remover Most patients have <10 genital warts, with a total wart area of of 0.5--1.0 cm2 , genital wart remover , genital wart medicationThese warts respond to most treatment modalities , genital wart remover , genital wart medicationFactors genital wart medication that may influence selection of treatment include wart size, wart number, anatomic site of wart, wart morphology, patient preference, cost of of treatment, convenience, convenience, adverse effects, and provider experience , genital wart remover , genital wart medicationMany patients require a course of therapy rather than a single treatment , genital wart remover , genital wart medicationIn general, warts located on moist surfaces and/or in intertriginous areas respond better to topical treatment genital wart medication treatment than do warts on drier surfaces , genital wart remover , genital wart medicationgenital wart medication genital wart remover |